Ralom, you ask a fundamental question - will AHZ survive until it turns cash-flow positive sometime in FY18. I believe it will - if we can trust the company's forecasts
We started FY17 with $8.8m, cap. raised apx $18m, can expect $3.5m (R&D tax rebate). This comes to apx. $30m.
In the Investor Presentation of 29.7.16 we have been told to expect a Loss of up to $10m.
This obviously leaves us with a Cash Balance of $20m to begin FY18.
However, how much has the recent court settlement cost? And will there be any unforseen circumstances?
None the less you would expect the new management to have allowed for both of these.
We just have to wait and see now as to whether their forecast figures re revenue growth & cost constraints are correct.....
Ralom, you ask a fundamental question - will AHZ survive until...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |